1. Cancer, cytokines, and cytotoxic celis. Kiin Wochenschr - I. Atzpodien J, Kirchner H. 68,1,1990  The tumor’ enhancement phenomenon.

2. Clerici M, Clerici E. J Nati Cancer Inst 88,461,1996.  A clinical study of the pineal giand activity in

3. Lissoni P, Viviani S, Bajetta E et al. oncologic patients. Cancer 57,837, 1986. The pineal gland beyond melatonin.

4. Lissoni P, Ardizzoia A, Rovelli F et al. mt J Med Environ 29,99,2001. Stimulation of murine splenocytes by melatonin and

5. Sze SF, Liu WK, Ng TB. methoxytryptamine. J Neural Transm Gen Sect 94,115,1993. The clinical neuroimmunotherapeutic role of melatonin in

6. Conti A, Maestroni GJM. oncology. J Pineal Res 19,103,1995. Perspectives in pineal functions.

7. Di Bella L, Rossi MT, Scalera G. Prog Brain Res 52,  475,1979. Is there a role for melatonin in supportive care? Supp Care Cancer 10,110, 

8. Lissoni P. 2002.   A randomised study with subcutaneous low-dose

9. Lissoni P, Barni S, Tancini G et al. interleukin—2 alone vs interleukin—2 plus the pineal neurohormone melatonin in advanced neoplasms other than renal cancer and melanoma. Br J Cancer 69,196,1994. 

Biotherapy with the pineai immunomoduiating

10. Lissoni P, Giani L, Zerbini S et al. hormone melatonin vs melatonin plus Aloe vera in untreatable advanced soiid neoplasms. Nat Immun 16,27,1998.